“In vitro” is a Latin term that translates to “in glass,” and it refers to any biological process or experiment that takes place outside a living body, typically in a laboratory setting. You’ve probably encountered it in the context of in vitro fertilization (IVF), but the term applies far more broadly. Whenever scientists study cells in a dish, test a drug on tissue samples, or grow bacteria in a flask, that work is happening in vitro.
What “In Vitro” Actually Means
The name comes from the glass containers, like test tubes and petri dishes, that scientists historically used to hold biological samples. Today, many of those containers are plastic, but the term stuck. The National Cancer Institute defines in vitro simply as “in the laboratory (outside the body).”
The opposite term is “in vivo,” which means “in the living.” An in vivo experiment happens inside a living organism, whether that’s a mouse, a human in a clinical trial, or any other animal. When you see a news headline saying a compound “killed cancer cells in vitro,” that means it worked in a lab dish, not inside a person. That distinction matters enormously because cells in a dish behave differently than cells inside a complex, living body.
How In Vitro Experiments Work
A typical in vitro setup involves growing living cells in carefully controlled conditions that mimic certain aspects of the body. Cells are placed in culture dishes or flasks filled with a nutrient-rich liquid called a growth medium. This medium contains amino acids, vitamins, sugars, minerals, growth factors, and hormones. Most formulations also include fetal bovine serum, a supplement derived from cattle that supplies additional proteins and nutrients cells need to survive and multiply.
The dishes sit inside incubators that tightly regulate temperature (usually around 37°C, matching human body temperature), humidity, and oxygen and carbon dioxide levels. All handling happens inside biosafety cabinets, which are enclosed workstations designed to keep the environment sterile. Even a small contamination from airborne bacteria or fungi can ruin an experiment.
Researchers can then introduce variables: adding a drug to one dish but not another, exposing cells to a virus, or changing nutrient levels to see how the cells respond. Because the environment is so controlled, it’s relatively easy to isolate a single variable and observe its effects, something that’s far harder to do inside a living body where thousands of processes happen simultaneously.
In Vitro Fertilization: The Most Famous Example
The most widely known application of in vitro technology is IVF. The process involves retrieving eggs from a woman’s ovaries, fertilizing them with sperm in a laboratory dish, and then transferring the resulting embryo back into the uterus. The “in vitro” part refers to that fertilization step happening outside the body rather than in the fallopian tube.
The first baby conceived through IVF was Louise Brown, born on July 25, 1978, at Oldham General Hospital in Manchester, United Kingdom. Her mother, Lesley Brown, had blocked fallopian tubes and had been unable to conceive for nine years. A gynecologist named Patrick Steptoe retrieved an egg during a natural ovulation cycle, and physiologist Robert Edwards fertilized it in the lab using the father’s sperm. A few days later, an eight-cell embryo was placed in Lesley’s uterus. Louise was delivered by cesarean section at 38 weeks and 5 days.
Modern IVF has become far more sophisticated. Patients now receive hormone injections to stimulate the ovaries into producing multiple eggs at once, and doctors monitor follicle growth with ultrasound and blood tests. Egg retrieval is performed under sedation using an ultrasound-guided needle. After fertilization, embryos typically grow in culture for five to seven days until they reach the blastocyst stage before being transferred or frozen. Fertilization success is checked 16 to 18 hours after sperm and egg are combined.
Drug Development and Safety Testing
Beyond fertility, in vitro methods are a cornerstone of how new medications get developed. Before any experimental drug reaches human volunteers, it goes through preclinical testing, and much of that early work happens in vitro. Researchers grow human cells in culture dishes and expose them to potential drug compounds to see whether the compounds have any therapeutic effect and whether they damage or kill the cells.
This stage is essentially a filter. Thousands of candidate molecules might be screened against panels of human cancer cell lines or other disease-relevant cells in a process called high-throughput screening. Only compounds that show both effectiveness and acceptable safety in these initial tests move forward to animal studies and, eventually, human clinical trials. In vitro screening is faster, cheaper, and more reproducible than jumping straight to animal testing.
In vitro methods also play a growing role in toxicology, the study of whether substances are harmful. Traditionally, safety testing for cosmetics, chemicals, and drugs relied heavily on animal experiments. Now, cell-based tests can replace some of those. For example, the neutral red uptake test, which measures how well cells survive exposure to a substance, serves as a substitute for the older Draize rabbit eye test that assessed eye irritation in live rabbits. Cell transformation assays can screen for cancer-causing potential without using rodents.
Advantages and Limitations
The biggest strengths of in vitro work are control and simplicity. You can isolate a single cell type, expose it to a precise concentration of a substance, and measure the response without the noise of an entire living system. Results are highly reproducible because the conditions can be standardized across different labs. The pharmaceutical industry favors in vitro methods for large-scale production work because of the ease of scaling up cell cultures compared to maintaining animal colonies. In vitro approaches also reduce the number of animals used in research, which carries both ethical and practical benefits.
The core limitation is that a dish of cells is not a human body. Inside you, drugs get absorbed through the gut, processed by the liver, distributed through the bloodstream, and eventually cleared by the kidneys. A cell sitting in a dish experiences none of that. A compound might kill cancer cells beautifully in a petri dish but fail completely in a living person because the body breaks it down before it ever reaches the tumor. Cells grown in flat, two-dimensional layers also behave differently from cells embedded in the three-dimensional architecture of real tissues, surrounded by blood vessels, immune cells, and connective tissue. This gap between lab results and real-world biology is why in vitro findings are considered preliminary. They’re a starting point, not a final answer.
Newer In Vitro Technologies
Scientists have been working to close the gap between the dish and the body. One of the most significant advances is organ-on-a-chip technology. These are small, engineered devices, often no bigger than a USB drive, that contain tiny channels lined with living human cells arranged to mimic the structure and function of a specific organ. A lung-on-a-chip, for example, can simulate breathing motions and airflow across lung tissue. A liver-on-a-chip can metabolize drugs the way a real liver would.
These systems recreate the three-dimensional, multicellular environment of actual organs far more accurately than a flat layer of cells in a dish. They can be tailored to mimic specific diseases, allowing researchers to study how a condition progresses and how it responds to treatment. One of the most promising directions is personalized medicine: building chips using cells derived from individual patients to predict how that specific person will respond to a drug, rather than relying on population averages.
Stem cell models represent another leap forward. Stem cells can be coaxed into becoming virtually any cell type, from heart muscle to brain neurons, giving researchers access to human tissues that would otherwise be impossible to study outside the body. These models are increasingly used for toxicity testing as alternatives to animal experiments, allowing safety assessments on human-relevant cells rather than rodent cells that may respond differently.
Why the Distinction Matters for Health News
Understanding what “in vitro” means changes how you read health and science headlines. When a study reports that a natural compound “destroyed 90% of cancer cells,” the critical question is where. If the answer is in vitro, the finding is interesting but very early-stage. It means the compound showed activity in a controlled lab setting, which is the first of many hurdles before it could become a treatment. The majority of compounds that work in vitro never make it through animal testing and human trials.
In vivo results, especially from human clinical trials, carry far more weight. The progression from in vitro to in vivo to clinical trial is the standard pipeline for medical research, and each stage filters out candidates that looked promising in the previous one. Knowing where a finding sits in that pipeline helps you gauge how excited, or how cautious, to be.